Google and GSK form venture to develop bioelectronic medicines

Britain's biggest drug company and Verily Life Sciences, a division of Alphabet, have teamed up to tackle chronic conditions

GlaxoSmithKline has teamed up with Google's parent company Alphabet to develop miniature electronic implants for the treatment of asthma, diabetes and other chronic conditions.

GSK, Britain's biggest drug company, said it would form a joint venture with Verily Life Sciences, a division of Alphabet, to work on research into bioelectronic medicines. GSK will own 55% of Galvani Bioelectronics, and Verily will hold 45%.